| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 19.42▲ | 19.59▼ | 19.59▼ | 19.56▼ | 20.43▼ |
| MA10 | 19.48▼ | 19.57▼ | 19.66▼ | 21.27▼ | 20.50▼ |
| MA20 | 19.58▼ | 19.66▼ | 19.72▼ | 20.70▼ | 22.23▼ |
| MA50 | 19.61▼ | 19.52▼ | 20.28▼ | 20.75▼ | 15.71▲ |
| MA100 | 19.62▼ | 20.55▼ | 21.11▼ | 22.11▼ | 10.89▲ |
| MA200 | 19.70▼ | 20.99▼ | 20.77▼ | 17.20▲ | 8.79▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.024▼ | -0.009▼ | 0.032▲ | -0.221▼ | -0.786▼ |
| RSI | 32.861▼ | 43.674▼ | 43.564▼ | 42.960▼ | 49.675▼ |
| STOCH | 9.679▼ | 63.682 | 36.629 | 14.672▼ | 26.302 |
| WILL %R | -81.356▼ | -62.637 | -73.016 | -86.043▼ | -88.881▼ |
| CCI | -78.919 | -34.781 | -70.176 | -77.077 | -74.383 |
| CDL | $AG Hammer Candlestick Pattern Detected | Set Alert |
|
Friday, May 22, 2026 10:11 PM
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Best ARK Stocks to Buy Right Now. On May 4, CRISPR Therapeutics AG (NASDAQ:CRSP) reported its first quarter 2026 results and advanced its pipeline ...
|
|
Friday, May 22, 2026 03:58 AM
On May 13, 2026, Bernstein raised the firm’s price target on CRISPR Therapeutics AG (NASDAQ:CRSP) to $56 from $50 while maintaining a Market Perform rating on the shares.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 19.70 | 19.785 | 19.095 | 19.45 | 8,322,949 |
| 21/05/26 | 19.38 | 20.37 | 19.25 | 19.90 | 9,205,206 |
| 20/05/26 | 19.30 | 20.05 | 18.85 | 19.94 | 10,969,788 |
| 19/05/26 | 19.47 | 19.55 | 18.63 | 18.80 | 15,839,780 |
| 18/05/26 | 20.78 | 20.815 | 19.625 | 19.73 | 11,215,915 |
| 15/05/26 | 21.36 | 21.40 | 20.01 | 20.42 | 18,220,542 |
| 14/05/26 | 23.80 | 23.80 | 22.63 | 22.66 | 13,374,286 |
| 13/05/26 | 24.09 | 24.48 | 23.0801 | 23.98 | 17,520,278 |
| 12/05/26 | 23.00 | 24.505 | 22.27 | 24.21 | 24,927,060 |
| 11/05/26 | 22.69 | 23.685 | 22.57 | 23.58 | 22,932,125 |
|
|
||||
|
|
||||
|
|